ECHA proposes additional control on pharma purifier chemical

Published: 22-Oct-2014
Ingredients

Because it can damage the environment


A chemical used to purify pharmaceuticals has been included in a draft list of new substances subject to special authorisation by the European Chemicals Agency (ECHA) for their manufacture or use in the European Union.

ECHA is consulting on adding ‘4-Nonylphenol, branched and linear, ethoxylated’, because it can damage the environment, as an endocrine disrupter.

  • Companies:
  • ECHA European Chemicals Agency
See more

You may also like

Ingredients

ECHA releases new chemical classification and labelling database

Read more
Aims to improve how ECHA makes this information available

Trending Articles

  1. 2BScientific expands its life science product supply service to Europe with new German facility The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. The rise of nutraceuticals in the pharmaceutical industry Driven by current market and consumer trends, pharmaceutical companies are increasingly embracing nutraceutical ingredients such as astaxanthin
  4. Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies
  5. Shasun Chemicals and Drugs Limited

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Ingredients

ECHA releases new chemical classification and labelling database

Aims to improve how ECHA makes this information available
Ingredients

Pharma chemicals in new ECHA toxicity assessment list

Ethylene oxide is recommended for classification as potentially causing allergic skin reactions
Ingredients

ECHA increases REACH fees

SMEs will continue to pay less than larger companies
Ingredients

ECHA probes safety of cobalt salts used in pharma

EC will use findings to decide whether ECHA should draft use restrictions
Ingredients

REACH review recommends cutting registration fees for SMEs

Improvements need to be made to quality of registration dossiers, says EC report
Ingredients

ECHA launches Public Classification and Labelling Inventory

Covering more than 90,000 chemical substances
Ingredients

ECHA Stakeholders' Day takes place today in Helsinki

Catch up with proceedings online
Subscribe now